Current Management of Low Risk Differentiated Thyroid Cancer and Papillary Microcarcinoma

被引:24
|
作者
Tarasova, V. D. [1 ]
Tuttle, R. M. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Serv Endocrinol, 1275 York Ave, New York, NY 10021 USA
关键词
Low risk thyroid cancer; papillary microcarcinoma; staging; BRAF V600E MUTATION; ACTIVE SURVEILLANCE; RADIOACTIVE IODINE; CARCINOMA; ASSOCIATION; RECURRENCE; STRATIFICATION; SURGERY; PROGNOSIS; IMPACT;
D O I
10.1016/j.clon.2016.12.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Each year, the proportion of thyroid cancer patients presenting with low risk disease is increasing. Moreover, the definition of low risk thyroid cancer is expanding and several histological subtypes beyond papillary microcarcinomas are now classified as low risk disease. This shift in the landscape of thyroid cancer presentation is forcing clinicians to critically re-evaluate whether or not traditional management paradigms that were effective in treating intermediate and high risk disease are applicable to these low risk patients. Here we review the definition of low risk disease, examine the various histological subtypes that are considered low risk in the 2015 American Thyroid Association guidelines for the management of thyroid nodules and thyroid cancer, and review our current approach to the management of these low risk tumours. (C) 2016 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.
引用
收藏
页码:290 / 297
页数:8
相关论文
共 50 条
  • [31] Surgery of papillary thyroid microcarcinoma
    Weber, T.
    Peth, S.
    Hummel, R.
    CHIRURG, 2018, 89 (06): : 415 - 421
  • [32] Clinicopathological characteristics and recurrence risk of papillary thyroid microcarcinoma in the elderly
    Wang, Xiaofei
    Lei, Jianyong
    Wei, Tao
    Zhu, Jingqiang
    Li, Zhihui
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 2371 - 2377
  • [33] US-guided Microwave Ablation of Low-Risk Papillary Thyroid Microcarcinoma: Longer-Term Results of a Prospective Study
    Yue, Wen-Wen
    Qi, Lu
    Wang, Dan-Dan
    Yu, Shou-Jun
    Wang, Xi-Ju
    Xu, Hui-Xiong
    Wang, Shu-Rong
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (06) : 1791 - 1800
  • [34] Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?
    Kaliszewski, Krzysztof
    Diakowska, Dorota
    Wojtczak, Beata
    Forkasiewicz, Zdzislaw
    Pupka, Dominika
    Nowak, Lukasz
    Rudnicki, Jerzy
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2019, 17 (1)
  • [35] Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival
    Krajewska, Jolanta
    Kukulska, Aleksandra
    Oczko-Wojciechowska, Malgorzata
    Kotecka-Blicharz, Agnieszka
    Drosik-Rutowicz, Katarzyna
    Haras-Gil, Malgorzata
    Jarzab, Barbara
    Handkiewicz-Junak, Daria
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [36] Diagnosis and treatment of low-risk papillary thyroid microcarcinoma
    Moon, Jae Hoon
    Park, Young Joo
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2018, 61 (04): : 232 - 240
  • [37] Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma
    Jeon, Min Ji
    Kim, Won Gu
    Kim, Tae Yong
    Shong, Young Kee
    Kim, Won Bae
    ENDOCRINOLOGY AND METABOLISM, 2021, 36 (04) : 717 - 724
  • [38] Influence of Initial Treatment on the Survival and Recurrence in Patients With Differentiated Thyroid Microcarcinoma
    Mihailovic, Jasna
    Stefanovic, Ljubomir
    Stankovic, Ranka
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (05) : 332 - 338
  • [39] Papillary Thyroid Microcarcinoma: Insights from a Cohort of 257 Thyroidectomized Patients
    Scherer, Henrique Cabral
    Fernandes, Paula Martins
    Scheffel, Rafael Selbach
    Zanella, Andre Borsatto
    Maia, Ana Luiza
    Dora, Jose Miguel
    HORMONE AND METABOLIC RESEARCH, 2023, 55 (03) : 161 - 168
  • [40] Patients' View on the Management of Papillary Thyroid Microcarcinoma: Active Surveillance or Surgery
    Yoshida, Yusaku
    Horiuchi, Kiyomi
    Okamoto, Takahiro
    THYROID, 2020, 30 (05) : 681 - 687